Gasimli, K.; Raab, M.; Mandal, R.; Krämer, A.; Peña-Llopis, S.; Tahmasbi Rad, M.; Becker, S.; Strebhardt, K.; Sanhaji, M.
Synergistic Sensitization of High-Grade Serous Ovarian Cancer Cells Lacking Caspase-8 Expression to Chemotherapeutics Using Combinations of Small-Molecule BRD4 and CDK9 Inhibitors. Cancers 2024, 16, 107.
https://doi.org/10.3390/cancers16010107
AMA Style
Gasimli K, Raab M, Mandal R, Krämer A, Peña-Llopis S, Tahmasbi Rad M, Becker S, Strebhardt K, Sanhaji M.
Synergistic Sensitization of High-Grade Serous Ovarian Cancer Cells Lacking Caspase-8 Expression to Chemotherapeutics Using Combinations of Small-Molecule BRD4 and CDK9 Inhibitors. Cancers. 2024; 16(1):107.
https://doi.org/10.3390/cancers16010107
Chicago/Turabian Style
Gasimli, Khayal, Monika Raab, Ranadip Mandal, Andrea Krämer, Samuel Peña-Llopis, Morva Tahmasbi Rad, Sven Becker, Klaus Strebhardt, and Mourad Sanhaji.
2024. "Synergistic Sensitization of High-Grade Serous Ovarian Cancer Cells Lacking Caspase-8 Expression to Chemotherapeutics Using Combinations of Small-Molecule BRD4 and CDK9 Inhibitors" Cancers 16, no. 1: 107.
https://doi.org/10.3390/cancers16010107
APA Style
Gasimli, K., Raab, M., Mandal, R., Krämer, A., Peña-Llopis, S., Tahmasbi Rad, M., Becker, S., Strebhardt, K., & Sanhaji, M.
(2024). Synergistic Sensitization of High-Grade Serous Ovarian Cancer Cells Lacking Caspase-8 Expression to Chemotherapeutics Using Combinations of Small-Molecule BRD4 and CDK9 Inhibitors. Cancers, 16(1), 107.
https://doi.org/10.3390/cancers16010107